OVERVIEW
The global market for apoptosis assays is expected to hit USD 7.12 billion by 2025, rising over the forecast period at a CAGR of 9.67%. Factors that contribute to this market’s growth include the increasing incidence and prevalence of chronic and infectious diseases, increased funding for cancer research, increased cell-based research, and the production of apoptosis-modulating drugs.
TABLE OF CONTENT
1 Global Apoptosis Assays Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Apoptosis Assays Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Apoptosis Assays Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Apoptosis Assays Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Apoptosis Assays Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Apoptosis Assays Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Apoptosis Assays Market – By Product (Market Size – & million/billion)
8.1 Reagents
8.2 Microplates
8.3 Instruments
8.4 Assay Kits
9 Global Apoptosis Assays Market – By Technology
9.1 Flow Cytometry
9.2 Cell Imaging & Analysis Systems
9.3 Spectrophotometry
9.4 Other
10 Global Apoptosis Assays Market – By Application
10.1 Drug Discovery & Development
10.2 Clinical & Diagnostic Applications
10.3 Basic Research
10.4 Stem Cell Research
11 Global Apoptosis Assays Market – By End-User
11.1 Pharmaceutical and Biotechnology Companies
11.2 Hospital and Diagnostic Laboratories
11.3 Academic and Research Institutes
12 Global Apoptosis Assays Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Apoptosis Assays Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Apoptosis Assays Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Merck KGaA
14.3 Thermo Fisher Scientific Inc.
14.4 Becton, Dickinson and Company
14.5 Sartorius AG
14.6 Biotium
14.7 Creative Bioarray (A Part of Creative Dynamics Inc.)
14.8 Bio-Rad Laboratories
14.9 Bio-Techne Corporation
14.10 Promega Corporation
14.11 Abcam PLC
14.12 Company 11 & more
15 Global Apoptosis Assays Market – Appendix
15.1 Sources
15.2 Abbreviations